Ian F. Smith

2009

In 2009, Ian F. Smith earned a total compensation of $9.1M as EVP & Chief Financial Officer at Vertex Pharmaceuticals, a 302% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$403,245
Option Awards$7,803,839
Salary$479,250
Stock Awards$405,297
Other$12,405
Total$9,104,036

Smith received $7.8M in option awards, accounting for 86% of the total pay in 2009.

Smith also received $403.2K in non-equity incentive plan, $479.3K in salary, $405.3K in stock awards and $12.4K in other compensation.

Rankings

In 2009, Ian F. Smith's compensation ranked 266th out of 9,885 executives tracked by ExecPay. In other words, Smith earned more than 97.3% of executives.

ClassificationRankingPercentile
All
266
out of 9,885
97th
Division
Manufacturing
90
out of 3,690
98th
Major group
Chemicals And Allied Products
25
out of 871
97th
Industry group
Drugs
22
out of 643
97th
Industry
Pharmaceutical Preparations
20
out of 446
96th
Source: SEC filing on April 10, 2012.

Smith's colleagues

We found six more compensation records of executives who worked with Ian F. Smith at Vertex Pharmaceuticals in 2009.

2009

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2009

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2009

Joshua Boger

Vertex Pharmaceuticals

Chief Executive Officer

2009

Peter Mueller

Vertex Pharmaceuticals

Chief Scientific Officer

2009

Amit Sachdev

Vertex Pharmaceuticals

Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada

2009

Kenneth Boger

Vertex Pharmaceuticals

Chief Legal Officer

News

In-depth

You may also like